Table 1.

Characteristics of COVID-19-convalescent patients, uninfected donors, and uninfected COVID-19-vaccinated donors for cellular and molecular assays

Donors for IFN-γ ELISpot assays and flow cytometric analysis
SARS-CoV-2-infected					Uninfected			Uninfected, COVID-19-vaccinated
No.	Sex	Age (years)	Days from 1st COVID+ test to blood draw	Days from 1st symptoms to blood draw	No.	Sex	Age (years)	No.	Sex	Age (years)	Days from 2nd COVID-19 vaccine dose to blood draw
1	M	74	22	11	1	F	32	1	F	32	74
2	F	89	4	5	2	F	27	2	M	67	80
3	M	52	37	36	3	M	38	3	F	35	71
4	F	61	5	5	4	F	35
5	F	25	94	98	5	F	58
6	F	25	6	11	6	M	26
7	M	36	69	n.k.	7	M	67
8	F	47	100	109	8	M	56
9	F	68	2	5
10	M	72	5	9
11	F	52	124	133
12	F	37	94	96
13	F	51	120	120
14	F	64	131	139
15	M	32	204	n.k.
16	M	54	13	13
17	M	52	96	n.k.
18	F	50	112	n.k.
Donors for V(D)J clonotyping and scRNA-seq studies
SARS-CoV-2-infected					Uninfected
No.	Sex	Age (years)	Days from first COVID+test to blood draw	Days from first symptoms to blood draw	No.	Sex	Age (years)
1	F	25	192	196	1	F	32
2	M	52	156	155	2	M	67
3	M	32	204	n.k.	3	F	35

Demographics of COVID-19-convalescent patients (SARS-CoV-2-infected as assessed by positive COVID-19 test), uninfected participants, and uninfected COVID-19-mRNA-vaccinated participants for IFN-γ ELISpot assays and flow cytometry studies, and SARS-CoV-2-infected and uninfected donors for V(D)J clonotyping and scRNA-seq studies. F, female; M, male; N/A, not applicable; n.k., not known.